Park Avenue Securities’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,811
| Closed | -$334K | – | 1427 |
|
|
2024
Q2 | $334K | Buy |
2,811
+266
| +10% | +$31.6K | ﹤0.01% | 1146 |
|
|
2024
Q1 | $271K | Sell |
2,545
-1,160
| -31% | -$124K | ﹤0.01% | 1210 |
|
|
2023
Q4 | $368K | Sell |
3,705
-1,770
| -32% | -$176K | 0.01% | 1035 |
|
|
2023
Q3 | $566K | Buy |
+5,475
| New | +$566K | 0.01% | 791 |
|
|
2023
Q1 | – | Sell |
-7,535
| Closed | -$1.35M | – | 997 |
|
|
2022
Q4 | $1.35M | Buy |
7,535
+1,314
| +21% | +$236K | 0.02% | 401 |
|
|
2022
Q3 | $736K | Buy |
6,221
+2,976
| +92% | +$352K | 0.01% | 582 |
|
|
2022
Q2 | $464K | Buy |
3,245
+808
| +33% | +$116K | 0.01% | 739 |
|
|
2022
Q1 | $420K | Buy |
2,437
+381
| +19% | +$65.7K | 0.01% | 817 |
|
|
2021
Q4 | $522K | Buy |
2,056
+166
| +9% | +$42.1K | 0.01% | 692 |
|
|
2021
Q3 | $727K | Buy |
1,890
+757
| +67% | +$291K | 0.01% | 520 |
|
|
2021
Q2 | $266K | Buy |
+1,133
| New | +$266K | 0.01% | 890 |
|